Yunteng Kang

General Hospital of Shenyang Military Region

Papers

1

Total Citations

3

H-Index

1

About

Dr. Yunteng Kang is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through robotic-assisted approaches. His most cited work, a 2018 paired case-controlled study, rigorously compared the short-term outcomes of Da Vinci robot-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) for non-small cell lung cancer. This landmark investigation demonstrated that the Da Vinci Surgical System, hailed as one of the 20th century’s greatest innovations, represents the future of precise minimally invasive surgery. Dr. Kang’s contributions have been instrumental in validating robotic lobectomy as a safe and effective alternative to traditional VATS, offering patients potentially improved recovery and surgical precision. With his work accumulating citations and shaping clinical practice, Dr. Kang stands at the forefront of thoracic oncology, bridging cutting-edge technology with patient-centered outcomes. His research continues to guide surgeons worldwide in adopting robotic platforms, solidifying his reputation as a key figure in the evolution of lung cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
[A Paired Case Controlled Study Comparing the Short-term Outcomes of Da Vinci RATS and VATS Approach for Non-small Cell Lung Cancer].
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: General Hospital of Shenyang Military Region

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago